<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80570">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01859247</url>
  </required_header>
  <id_info>
    <org_study_id>UNM 657</org_study_id>
    <secondary_id>U54NS065701</secondary_id>
    <nct_id>NCT01859247</nct_id>
  </id_info>
  <brief_title>Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study</brief_title>
  <official_title>Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dystonia Coalition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this application is to therapeutically target the dysfunctional
      premotor-motor interaction in dystonia—and to provide a focused treatment of specific
      anatomical networks in order to reduce side effects and to improve symptom control over
      conventional therapies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose using repetitive transcranial magnetic stimulation (rTMS) over distinct premotor
      areas in patients with cervical dystonia (CD) with the goal of improving symptoms and
      reducing unwanted side effects.  The knowledge gained in this proposed research will
      identify a specific premotor area to be targeted with rTMS that is expected to result in a
      novel intervention that could enhance or replace current treatments for CD. rTMS could be
      included as an adjunct treatment to botulinum toxin that could sustain treatment effect and
      decrease the frequency of re-injection, potentially resulting in cost savings without a
      decrease in symptom control. In addition to medical cost reduction, improved quality of life
      could be expected with the successful development of therapies that extend dystonia symptom
      control. rTMs has been FDA-approved for the treatment of depression and our proposal uses an
      even lower stimulation rate, suggesting continued use within clearly safe parameters.
      Successful completion of this research could lead to rapid adoption of this therapeutic
      modality.

      We will test the hypothesis that rTMS of a distinct premotor site will provide more
      effective treatment of CD than non-specific activation of the entire premotor region.  This
      will be done by performing a randomized, observer-blinded exploratory pilot study to
      determine the optimal site of rTMS over various sites of the premotor and motor cortex to
      improve the symptoms of cervical dystonia.  Completion of this aim should lead to
      development of targeted TMS therapy for CD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)</measure>
    <time_frame>Change from baseline pre-intervention TWSTRS score to post-intervention within 1 hour of treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dorsal Premotor-motor inhibition (dPMI)</measure>
    <time_frame>Change from baseline dPMI to post-intervention within 1 hour of treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite measure of patient rating of symptoms and tolerability</measure>
    <time_frame>Change from baseline dPMI to post-intervention within 1 hour of treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>This measure will confirm the intervention tolerability by the patient.  He/she will score the tolerability from 0-10, 0 being &quot;completely tolerable&quot; and 10 &quot;completely untolerable.&quot;</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Cervical Dystonia</condition>
  <condition>Spasmodic Torticollis</condition>
  <arm_group>
    <arm_group_label>Dorsal Premotor rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary motor cortex rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supplemental Motor Area rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anterior Cingulate rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <arm_group_label>Dorsal Premotor rTMS</arm_group_label>
    <arm_group_label>Primary motor cortex rTMS</arm_group_label>
    <arm_group_label>Supplemental Motor Area rTMS</arm_group_label>
    <arm_group_label>Anterior Cingulate rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of idiopathic cervical dystonia

          -  Age 18 years or older

          -  Normal findings in the medical history, physical and neurological examination, except
             for dystonia

          -  Last treatment with botulinum toxin more than two months ago

        Exclusion Criteria:

          -  History of seizure disorder

          -  Pregnancy- a pregnancy test will be performed for women of childbearing potential

          -  History of any other neurological disorders or conditions requiring the use of
             anti-depressants that are known to increase seizure threshold, neuroleptic
             medication, anticholinergic drugs and muscle relaxants

          -  History of neuroleptic medications/ prior use of neuroleptics
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Pirio Richardson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H.A. Jinnah, MD</last_name>
    <role>Study Director</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meg Radigan</last_name>
    <phone>505-272-8740</phone>
    <email>mradigan@salud.unm.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meg Radigan</last_name>
      <email>mradigan@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Sarah Pirio Richardson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meg Radigan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://rarediseasesnetwork.epi.usf.edu/dystonia/</url>
    <description>Dystonia Coalition</description>
  </link>
  <reference>
    <citation>Beck S, Houdayer E, Richardson SP, Hallett M. The role of inhibition from the left dorsal premotor cortex in right-sided focal hand dystonia. Brain Stimul. 2009 Oct;2(4):208-14. doi: 10.1016/j.brs.2009.03.004. Epub 2009 May 3.</citation>
    <PMID>20633420</PMID>
  </reference>
  <reference>
    <citation>Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci. 2008 Mar;9(3):222-34. doi: 10.1038/nrn2337. Review.</citation>
    <PMID>18285800</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, Fénelon G, Ménard-Lefaucheur I, Wendling S, Nguyen JP. Low-frequency repetitive TMS of premotor cortex can reduce painful axial spasms in generalized secondary dystonia: a pilot study of three patients. Neurophysiol Clin. 2004 Oct;34(3-4):141-5.</citation>
    <PMID>15501683</PMID>
  </reference>
  <reference>
    <citation>Murase N, Rothwell JC, Kaji R, Urushihara R, Nakamura K, Murayama N, Igasaki T, Sakata-Igasaki M, Mima T, Ikeda A, Shibasaki H. Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain. 2005 Jan;128(Pt 1):104-15. Epub 2004 Oct 13.</citation>
    <PMID>15483042</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 17, 2013</lastchanged_date>
  <firstreceived_date>May 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of New Mexico</investigator_affiliation>
    <investigator_full_name>Sarah Pirio Richardson</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>cervical dystonia</keyword>
  <keyword>torticollis</keyword>
  <keyword>rTMS</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
    <mesh_term>Torticollis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
